• A comparison of obstetric and neonatal outcomes in polycystic ovary syndrome and congenital adrenal hyperplasia: a retrospective analysis of a population database
• A comparison of obstetrical and neonatal outcomes in PCOS and CAH: a retrospective analysis of a population database
• A Humanized and Viable Animal Model for Congenital Adrenal Hyperplasia-<em>CYP21A2</em>-R484Q Mutant Mouse
• ACTH-producing adrenocortical carcinoma: an exceedingly rare diagnosis
• Ameliorative potential of rosmarinic acid in a rat model of polycystic ovary syndrome: Targeting MCP-1 and VEGF: A histological, immunohistochemical, and biochemical study
• Androgens Modulate the Immune Profile in a Mouse Model of Polycystic Ovary Syndrome
• Anti-Müllerian Hormone: A Molecular Key to Unlocking Polycystic Ovary Syndrome?
• Apelin receptor modulation mitigates letrozole-induced polycystic ovarian pathogenesis in mice
• Artemisinins ameliorate polycystic ovarian syndrome by mediating LONP1-CYP11A1 interaction
• Association between Coffee Consumption and Polycystic Ovary Syndrome: An Exploratory Case-Control Study
• Association of <em>TCF7L2</em> Gene Variant (rs12255372) with Polycystic Ovary Syndrome and its Effect Modification of the Disease Phenotype
• Case report: A pregnant woman accidental treated with spironolactone in mid-gestation
• Case Report: Hyperandrogenism in Menopause
• Causal relationships between modifiable risk factors and polycystic ovary syndrome: a comprehensive Mendelian randomization study
• Clustering Identifies Subtypes With Different Phenotypic Characteristics in Women With Polycystic Ovary Syndrome
• Combined contraceptive pills for androgen excess, not for polycystic ovary syndrome in adolescent girls
• Comparing GDF9 in mature follicles and clinical outcomes across different PCOS phenotype
• Contrasting bone profiles in PCOS are related to BMI: a systematic review and meta-analysis
• Correlation of Polycystic Ovarian Syndrome Phenotypes With Pregnancy and Neonatal Outcomes
• CYP21A2 Intron 2 Genetic Variants Might Be Associated with the Clinical Characteristics of Women with PCOS
• Cytoarchitectural differences in reproductive organs of some polycystic ovary-like induced animal models
• Decreased AMPK/SIRT1/PDK4 induced by androgen excess inhibits human endometrial stromal cell decidualization in PCOS
• Demographic and Clinical Characteristics of Patients with Adrenal Incidentaloma from a Single Center in South India: A Retrospective Study
• Depression in Polycystic Ovary Syndrome: Focusing on Pathogenesis and Treatment
• Depression, higher level of tension induction, and impaired coping strategies in response to stress in women with PCOS correlate with clinical and laboratory indices of hyperandrogenism and not with central obesity and insulin resistance
• Diagnosis, Management, and Associated Comorbidities of Polycystic Ovary Syndrome: A Narrative Review
• Downregulation of CASC15 attenuates the symptoms of polycystic ovary syndrome by affecting granulosa cell proliferation and regulating ovarian follicular development
• Early- to mid-gestational testosterone excess leads to adverse cardiac outcomes in postpartum sheep
• Effects of vitamin D supplementation on oxidative stress biomarkers of Iranian women with polycystic ovary syndrome: a meta-analysis study
• Efficacy and safety of glucagon-like peptide-1 receptor agonists in the treatment of polycystic ovary syndrome-A systematic review and meta-analysis
• Efficacy and Safety of Osilodrostat in Managing Cushing's Syndrome: A Systematic Review and Meta-Analysis
• Elucidating metformin action on the ovary and fertility in healthy mice
• Endoplasmic reticulum stress-mediated ferroptosis in granulosa cells contributes to follicular dysfunction of polycystic ovary syndrome driven by hyperandrogenism
• Ethnicity and the Prevalence of Polycystic Ovary Syndrome: The Eastern Siberia PCOS Epidemiology and Phenotype Study
• Evaluation of CRP/Albumin Ratio in Polycystic Ovarian Syndrome
• Evaluation of oxidative stress and inflammation in patients with polycystic ovary syndrome
• Exploring the Antioxidative Effects of Ginger and Cinnamon: A Comprehensive Review of Evidence and Molecular Mechanisms Involved in Polycystic Ovary Syndrome (PCOS) and Other Oxidative Stress-Related Disorders
• Fisetin mitigates letrozole-induced polycystic ovarian syndrome in rats: crosstalk of AMPK/PI3K/AKT-mediated-Nrf2 antioxidant defense mechanism and the inflammasome NLRP3/NF-κB P65/IL-1β signaling pathways
• Free Androgen Index Might Not Be a Perfect Predictor of Infertility Outcomes in Patients with Polycystic Ovary Syndrome Undergoing Frozen Embryo Transfer:A Retrospective Cohort Study
• Genetic Association Between Polycystic Ovary Syndrome and the <em>APOA5</em> rs662799 and <em>PLIN1</em> rs894160 Metabolic Variants in the Western Saudi Population: A Case-Control Study
• Genetic Causation Analysis of Hyperandrogenemia Testing Indicators and Preeclampsia
• Gestational age-specific reference intervals for androgens in pregnancy
• Has the name PCOS run its course?
• Hereditary Severe Insulin-resistance Syndrome and Acanthosis Nigricans Caused by Novel Mutations in the <em>INSR</em> Gene
• Hyperandrogenemia elevates expression of apelin and apelin receptor protein in the mice pituitary
• Hyperandrogenic environment regulates the function of ovarian granulosa cells by modulating macrophage polarization in PCOS
• Hyperandrogenism and Hypokalemic Thyrotoxic Periodic Paralysis in a North American Adolescent Girl
• Hyperandrogenism Decreases Seizure Threshold in A Rat Model of Polycystic Ovary Syndrome
• Influence of state-of-the-art laboratory techniques on the phenotyping of women with polycystic ovary syndrome in the clinical setting
• Interlukin-22 improves ovarian function in polycystic ovary syndrome independent of metabolic regulation: a mouse-based experimental study
• Investigating GABA Neuron-Specific Androgen Receptor Knockout in two Hyperandrogenic Models of PCOS
• Irregular Cycles, Ovulatory Disorders, and Cardiometabolic Conditions in a US-Based Digital Cohort
• Kallistatin as a Potential Biomarker in Polycystic Ovary Syndrome: A Prospective Cohort Study
• Klotho accelerates the progression of polycystic ovary syndrome through promoting granulosa cell apoptosis and inflammation
• Memory in female adolescents with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
• Metabolic characteristics of different phenotypes in reproductive-aged women with polycystic ovary syndrome
• Metabolic Dysfunction-Associated Steatotic Liver Disease and Polycystic Ovary Syndrome: A Complex Interplay
• MicroRNA-21 modulates brown adipose tissue adipogenesis and thermogenesis in a mouse model of polycystic ovary syndrome
• Mitochondrial dysfunction results in enhanced adrenal androgen production in H295R cells
• New characteristics of polycystic ovary syndrome phenotypes according to gas chromatography-mass spectrometry-based study of urinary steroid metabolome
• Obesity and polycystic ovary syndrome influence on intestinal permeability at fasting, and modify the effect of diverse macronutrients on the gut barrier
• Ovarian hyperthecosis in adolescent females: two case reports and a review of the literature
• Polycystic Ovarian Syndrome among Young Women of a University in Central Gujarat - A Cross-sectional Study
• Polycystic ovary syndrome: A review of diagnosis and management, with special focus on atherosclerotic cardiovascular disease prevention
• Polycystic ovary syndrome: Insights into its prevalence, diagnosis, and management with special reference to gut microbial dysbiosis
• Practise Updates: Diagnosis and Management of Idiopathic Hirsutism
• Pregnancy complications and birth outcomes in women with polycystic ovary syndrome undergoing frozen embryo transfer
• Prevalence and association of polycystic ovary syndrome and hidradenitis suppurativa in underrepresented groups
• Prevalence and correlates of diagnosed and probable polycystic ovary syndrome (PCOS) in a cohort of parous women
• Prevalence and diagnosis of polycystic ovary syndrome (PCOS) in adolescents - what's new in 2023? Systematic review
• Primary disease of adipose tissue: When to think about and how to evaluate it in clinical practice?
• Protective Potential of Methanol Extract of Drymaria cordata Willd. ex Schult (MEDC) on Letrozole-Induced Polycystic Ovary Syndrome Via Modulation of Apoptotic Markers, Sex Hormones and Antioxidant Status in Rat Model
• Research progress of chemerin in polycystic ovary syndrome
• Rodent models in polycystic ovarian Syndrome: Dissecting reproductive and metabolic phenotypes for therapeutic Advancements
• Role of Branched-Chain Amino Acids in Metabolic Changes of Polycystic Ovary Syndrome
• Role of vitamin D and leptin levels in PCOS in young women: A family medicine perspective
• Severe Carpal Tunnel Syndrome in a Pediatric Patient With a History of Congenital Adrenal Hyperplasia
• SFRP4 contributes to insulin resistance-induced polycystic ovary syndrome by triggering ovarian granulosa cell hyperandrogenism and apoptosis through the nuclear beta-catenin/IL-6 signaling axis
• Strong Early Impact of Letrozole on Ovulation Induction Outperforms Clomiphene Citrate in Polycystic Ovary Syndrome
• Targeted inhibition of kisspeptin neurons reverses hyperandrogenemia and abnormal hyperactive LH secretion in a preclinical mouse model of polycystic ovary syndrome
• The association between female sexual function and metabolic features of the polycystic ovary syndrome in Turkish women of reproductive age
• The Association between Obesity and Polycystic Ovary Syndrome: An Epidemiologic Study of Observational Data
• The Comparison of Irisin, Subfatin, and Adropin in Normal-Weight and Obese Polycystic Ovary Syndrome Patients
• The Effect of BMI and Lipid Metabolism on Pregnancy Outcomes of PCOS Patients Treated with ICSI_IVF
• The efficacy and safety of GLP-1 agonists in PCOS women living with obesity in promoting weight loss and hormonal regulation: A meta-analysis of randomized controlled trials
• The gut microbial composition in polycystic ovary syndrome with hyperandrogenemia and its association with steroid hormones
• The IL-12 family of heterodimeric cytokines in polycystic ovarian syndrome: biological role in induction, regulation, and treatment
• The impact of androgen levels on serum metabolic profiles in patients with polycystic ovary syndrome
• The impact of hyperandrogenemia on pregnancy complications and outcomes in patients with PCOS: a systematic review and meta-analysis
• The Landscape of Androgens in Cushing's Syndrome
• The latest reports and treatment methods on polycystic ovary syndrome
• The positive association between hyperuricemia and polycystic ovary syndrome and analysis of related factors
• Therapeutic potential of acarbose in ameliorating the metabolic and endocrinological complications of polycystic ovarian syndrome: a review
• Transcriptome Analysis of Mesenchymal Progenitor Cells Revealed Molecular Insights into Metabolic Dysfunction and Inflammation in Polycystic Ovary Syndrome
• Type B insulin resistance syndrome: A case report
• Unveiling the Role of Artificial Intelligence (AI) in Polycystic Ovary Syndrome (PCOS) Diagnosis: A Comprehensive Review
• Use of placental-derived mesenchymal stem cells to restore ovarian function and metabolic profile in a rat model of the polycystic ovarian syndrome
• Validation of the follicular and ovarian thresholds by an 18-MHz ultrasound imaging in polycystic ovary syndrome: a pilot cutoff for North African patients
• Vitamin D deficiency, insulin resistance and anti-mullerian hormone: a tale of trio in expression of polycystic ovary syndrome
• Vitamin D deficiency, insulin resistance, and antimüllerian hormone level: a tale of trio in the expression of polycystic ovary syndrome